Sign in
4

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001873394-25-000003

President, Research & Develop. gave up 1,760 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Sethuraman Natarajan President, Research & Develop. 2025-09-02 Shares withheld for taxes −1,760 $5.43 $9,557 197,899 D
Loading xslF345X05/wk-form4_1757019782.xml…